Article Versions Notes

Lin Y-L, Lin S-H, Wang H-H, Hsu W-C, Hung S-Y, Chiou Y-Y, Liou H-H, Chang M-Y, Ho L-C, Wu C-F, et al. Role of Metformin in Preventing New-Onset Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus. Pharmaceuticals. 2025; 18(1):95. https://doi.org/10.3390/ph18010095

Lin, Yu-Ling, Sheng-Hsiang Lin, Hsi-Hao Wang, Wan-Chia Hsu, Shih-Yuan Hung, Yuan-Yow Chiou, Hung-Hsiang Liou, Min-Yu Chang, Li-Chun Ho, Ching-Fang Wu, and et al. 2025. "Role of Metformin in Preventing New-Onset Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus" Pharmaceuticals 18, no. 1: 95. https://doi.org/10.3390/ph18010095

Lin, Y.-L., Lin, S.-H., Wang, H.-H., Hsu, W.-C., Hung, S.-Y., Chiou, Y.-Y., Liou, H.-H., Chang, M.-Y., Ho, L.-C., Wu, C.-F., & Lee, Y.-C. (2025). Role of Metformin in Preventing New-Onset Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus. Pharmaceuticals, 18(1), 95. https://doi.org/10.3390/ph18010095